Key Takeaways
- China's cyberspace regulator has instructed major tech companies, including Alibaba (BABA) and ByteDance, to halt orders for Nvidia's (NVDA) RTX Pro 6000D AI chips, a move that sent Nvidia shares down 2.7% and is aimed at boosting domestic alternatives amid ongoing U.S.-China trade tensions.
- The Federal Reserve has cut interest rates by 25 basis points to a range of 4.00%-4.25% due to a weakening U.S. labor market, with further cuts anticipated, influencing the USD/JPY pair which dipped close to 146.20.
- Thai Prime Minister Anutin Charnvirakul has confirmed his cabinet line-up, though it faces scrutiny over ethical and legal requirements, while simultaneously pledging a swift economic recovery and pushing a $31.5 billion Land Bridge mega-project.
- Pharmaceutical firms have pledged a massive $350 billion investment in U.S. manufacturing, including significant commitments from GSK (GSK) ($30B) and Eli Lilly (LLY) ($5B), in response to looming 250% import tariffs.
- China's CSI Semiconductor Material & Equipment Index surged by 6%, signaling strong domestic growth in the sector, potentially benefiting from Beijing's push for technological self-reliance.
Global financial markets are reacting to a series of significant developments, from escalating technological restrictions between the U.S. and China to shifts in monetary policy and political landscapes. A notable event is China's directive to its leading technology firms to cease purchasing advanced AI chips from Nvidia (NVDA), intensifying the ongoing tech rivalry.
China's AI Chip Ban Hits Nvidia, Boosts Domestic Semiconductor Sector
China's cyberspace regulator has issued a stern directive to major domestic tech companies, including Alibaba Group Holding Ltd. (BABA) and ByteDance, to discontinue orders and testing of Nvidia's (NVDA) RTX Pro 6000D AI chips. This particular chip was reportedly designed by Nvidia to navigate existing U.S. export restrictions on advanced AI hardware to China. The news prompted a 2.7% slide in Nvidia shares in U.S. trading, with rival Advanced Micro Devices (AMD) also seeing a nearly 1% decline.
This move underscores Beijing's broader strategy to reduce its reliance on U.S. technology and foster the growth of indigenous alternatives. The ban is considered more stringent than previous guidance concerning Nvidia's H20 chip. In a related development, Alibaba's (BABA) T-Head chipmaking division has reportedly secured China Unicom as a client for its AI chips, highlighting the country's accelerating efforts in domestic semiconductor development. Amid these tensions, U.S. President Donald Trump and Chinese President Xi Jinping are expected to hold a call, with trade issues central to their discussions.
Coinciding with this push for self-sufficiency, China's CSI Semiconductor Material & Equipment Index surged by 6% in the market. This robust performance is attributed to the burgeoning era of AI and a continuous recovery in downstream sectors, further propelled by the national drive for domestic substitution in critical technologies.
Fed Rate Cut Impacts USD/JPY, Pharmaceutical Firms Pledge US Investment
The Federal Reserve has announced a 25-basis-point interest rate cut, bringing the benchmark rate to a range of 4.00%-4.25%. This decision, driven by concerns over a weakening U.S. labor market and recent soft jobs data, signals the likelihood of additional rate reductions in the near future. Notably, new Fed Governor Stephen Miran cast a dissenting vote, advocating for a more aggressive 50-basis-point cut.
The anticipation and execution of these rate cuts have significantly influenced currency markets, with the USD/JPY pair dipping close to 146.20. The pair's movement has been closely tied to shifting rate expectations and the spread between U.S. and Japanese 10-year yields.
In other economic news, major pharmaceutical companies are committing substantial investments in U.S. manufacturing. Firms, including GSK (GSK) with a $30 billion pledge and Eli Lilly (LLY) with $5 billion, are collectively investing $350 billion in onshore production. This strategic move aims to expand biologics capacity and mitigate risks associated with potential 250% import tariffs.
Thailand's New Cabinet Faces Scrutiny, PM Pledges Economic Revival
In Thailand, Prime Minister Anutin Charnvirakul has confirmed that his cabinet line-up has been submitted to His Majesty the King for royal endorsement. However, the formation of the new government faces immediate challenges, with reports indicating that the Privy Council has raised concerns over the ethical and legal qualifications of several ministerial nominees. This scrutiny could potentially destabilize the new administration before it fully commences its work. The cabinet is composed of 36 members representing various political parties.
Despite these political hurdles, Prime Minister Anutin is pushing forward with ambitious economic plans. He has pledged a swift recovery to stronger economic growth, promising to dismantle bureaucratic obstacles and revitalize local industries within a four-month timeframe. Key objectives include increasing local content and transitioning Thailand's manufacturing sector from an Original Equipment Manufacturer (OEM) model to producing competitive Thai brands. Anutin also aims to position Thailand as a manufacturing hub for the CLMV (Cambodia, Laos, Myanmar, Vietnam) region. A significant part of his economic strategy involves driving the $31.5 billion Land Bridge mega-project, designed to stimulate the economy and attract long-term investment. These efforts come as Thailand's economy, which grew by 2.4% in 2024, is projected to slow to 1.8% in 2025, according to a downgraded forecast by the World Bank.
Separately, an agribusiness leader has been appointed to the Reserve Bank of New Zealand's (RBNZ) Monetary Policy Committee, a development that will be closely watched for its implications on the country's monetary policy direction.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.